JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001937200 on April 11, 2000

J. Biol. Chem., Vol. 275, Issue 24, 18114-18120, June 16, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/24/18114    most recent
M001937200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hresko, R. C.
Right arrow Articles by Mueckler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hresko, R. C.
Right arrow Articles by Mueckler, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Novel 68-kDa Adipocyte Protein Phosphorylated on Tyrosine in Response to Insulin and Osmotic Shock*

Richard C. Hresko and Mike MuecklerDagger

From the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110

Received for publication, March 8, 2000, and in revised form, April 4, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Osmotic shock can cause insulin resistance in 3T3-L1 adipocytes by inhibiting insulin activation of glucose transport, p70S6 kinase, glycogen synthesis, and lipogenesis. By further investigating the relationship between insulin and hypertonic stress, we have discovered that osmotic shock enhanced by 10-fold the insulin-stimulated tyrosine phosphorylation of a 68-kDa protein. Phosphorylation by insulin was maximal after 1 min and was saturated with 50-100 nM insulin. The effect of sorbitol was completely reversible by 2.5 min. pp68 was a peripheral protein that was localized to the detergent insoluble fraction of the low density microsomes but was not associated with the cytoskeleton. Stimulation of the p42/44 and the p38 MAP kinase pathways by osmotic shock had no effect on pp68 phosphorylation. Treatment of adipocytes with the phosphotyrosine phosphatase inhibitor phenylarsine oxide also enhanced insulin-activated tyrosine phosphorylation of pp68 suggesting that osmotic shock may increase pp68 phosphorylation by inhibiting a phosphotyrosine phosphatase. Dissociation of pp68 from the low density microsomes with RNase A indicated that pp68 binds to RNA. Failure to immunoprecipitate pp68 using antibodies directed against known 60-70-kDa tyrosine-phosphorylated proteins suggest that pp68 may be a novel cellular target that lies downstream of the insulin receptor.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The metabolic and mitogenic effects of insulin are initiated by the binding of the hormone to specific cell surface receptors that results in the autophosphorylation of critical tyrosine residues, which then activates an intrinsic tyrosine kinase (1). Insulin receptor substrate-1 (IRS-1)1 and SHC, the two best characterized substrates of the insulin receptor tyrosine kinase, serve as docking sites for various SH2 domain-containing proteins to generate multiple independent cellular signals that ultimately lead to various downstream biological responses (2, 3). Tyrosine-phosphorylated IRS-1 is known to bind to two regulatory subunits of PI 3-kinase, p85 and p55, Grb2, the tyrosine phosphatase Syp, Fyn, Nck, and Crk (4-6). PI 3-kinase has been implicated in a wide variety of insulin effects that include stimulation of glucose transport through the translocation of Glut 4 to the cell surface, activation of glycogen synthesis, inhibition of lipolysis, and induction of membrane ruffling (7). SHC can also bind to Grb2 (8), and through its interaction with mSOS it can cause Ras activation and subsequent increased mitogensis (9).

Osmotic shock has been shown to increase glucose uptake in 3T3-L1 adipocytes by stimulating the translocation of Glut 4 to the cell surface (10). The signal transduction pathway is distinct from insulin in that it fails to activate PI 3-kinase or AKT. Interestingly, treatment of cells with the tyrosine kinase inhibitor genistein or microinjection of phosphotyrosine antibodies blocks both insulin and sorbitol-induced Glut 4 translocation, suggesting a tyrosine kinase signaling cascade is important for both pathways. The stimuli are not additive. Furthermore, a subsequent study showed that pretreatment with 600 mM sorbitol inhibits insulin from further increasing glucose transport (11). Although early insulin signaling such as insulin receptor autophosphorylation, tyrosine phosphorylation of IRS-1, and activation of PI 3-kinase are normal, osmotic stress inhibits insulin activation of AKT by stimulating a phosphatase that maintains Thr308 and Ser473 of AKT in the dephosphorylated state. Activation of a similar or identical phosphatase may be responsible for the inhibition of both basal and insulin-stimulated p70S6 kinase activities by hypertonic shock (12). Pretreatment with the phosphatase inhibitors okadaic acid or calyculin A prevents the inhibition of insulin activation of AKT (11) and the deactivation of p70S6 kinase (12). It is not known whether sorbitol activates the phosphatase through an intrinsic activation mechanism or by altering the subcellular localization of the enzyme or substrate.

In the present study we further investigate the effects of osmotic shock on insulin action. Pretreatment of 3T3-L1 adipocytes with 600 mM sorbitol enhances by 10-fold the insulin-stimulated tyrosine phosphorylation of a 68-kDa protein. Additional characterization indicates that this protein is a peripheral protein that resides in the detergent-insoluble fraction of low density microsomes (LDM) by binding to RNA.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Cytochalasin D, nocodazole, poly(A)-Sepharose 4B, and poly(U)-agarose were purchased from Sigma. Latrunculin B was from BioMol. PD 98059 and SB 203580 were from Calbiochem. Phenylarsine oxide was purchased from Aldrich.

Subcellular Fractionation of 3T3-L1 Adipocytes-- 3T3-L1 fibroblasts were grown to confluence and 48 h later subjected to differentiation as described previously (13). 3T3-L1 adipocytes were used 10-14 days after differentiation. Cells were washed three times with phosphate-buffered saline and incubated for at least 2 h to overnight in serum-free Dulbecco's modified Eagle's medium (DMEM). Adipocytes were then incubated with DMEM alone or DMEM supplemented with insulin or sorbitol. After the treatment, cells were washed three times with ice-cold phosphate-buffered saline, scraped in 2 ml/10-cm dish of ice-cold HES (255 mM sucrose, 20 mM HEPES, pH 7.4, and 1 mM EDTA) containing 100 mM sodium fluoride, 10 mM sodium pyrophosphate, 1 mM sodium vanadate, and protease inhibitors and then homogenized by passing the cells 10 times through a Yamato LSC homogenizer at a speed of 1200 rotations/min at 4 °C. Subcellular fractionation was carried out by differential centrifugation as described previously (14). The following protease inhibitors were used: 1 µg/ml leupeptin, 1 µg/ml antipain, 1 µg/ml benzamidine, 5 µg/ml trypsin inhibitor, 1 µg/ml chymostatin, 1 µg/ml pepstatin A, and 0.5 mM phenylmethylsufonyl fluoride.

Western Blot Analysis-- 50 µg of protein were subjected to SDS-polyacrylamide gel electrophoresis and then transferred to nitrocellulose. Phosphotyrosine-phosphorylated proteins were detected using the monoclonal PY-20 antibody (Transduction Laboratories). 125I-Labeled goat anti-mouse IgG (0.25 µCi/ml, ICN, Irvine, CA) was used as the secondary antibody. Radioactive bands were quantitated by a PhosphoImager SI Analyzer (Molecular Dynamics). The phospho-specific antibodies, phospho-p42/44 MAP kinase (Thr202/Tyr204) E10 monoclonal antibody, phospho-p38 MAP kinase (Thr180/Tyr182) antibody, and the phospho-SAPK/JNK (Thr183/Tyr185) antibody, were from New England Biolabs. Enhanced chemiluminescence was used for the detection.

Immunoprecipitation of Possible Candidate and Interacting Proteins-- 0.5-1.0 mg of LDM were solubilized with 0.5-1 ml of Buffer A (50 mM HEPES, pH 7.4, 1 mM EDTA, 150 mM NaCl, 1 mM sodium vanadate, 100 mM sodium fluoride, 10 mM sodium pyrophosphate, 1% Triton X-100, and protease inhibitors). After centrifugation for 10 min at 4 °C in a microfuge, the supernatant was incubated overnight with 4 µg of primary antibody. 50 µl of protein A-Sepharose or 50 µl of goat anti-mouse IgG affinity gel (Cappel, ICN) were added for 2 h at 4 °C to the reactions that contained polyclonal or monoclonal primary antibodies, respectively. After washing pellets four times with ice-cold Buffer A containing detergent and twice with Buffer A without detergent, proteins were eluted with SDS sample buffer. The immunoprecipitates were subjected to SDS-polyacrylamide gel electrophoresis and analyzed by Western blot using PY20 antiphosphotyrosine antibodies as described above. Antibodies directed against SHC, RasGAP, Paxillin, Sam68, Grb2, and Nck were purchased from Transduction Laboratories. Cbl, Cas, p62Dok, Fyn, and IRS-3 antibodies were from Santa Cruz. Fak, PTP1C, Pyk2, Syp, Src, and PI 3-kinase antibodies were from Upstate Biotechnology. Polyclonal antibodies directed against Glut 4 transporter and IRS-1 were generated by immunizing rabbits with peptides corresponding to the final 16 amino acids of each protein. Determination of whether the immunoprecipitations were successful was carried out by Western blot analyses of aliquots of the supernatants before and after immunoprecipitation.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Insulin-induced Tyrosine Phosphorylation of a 68-kDa Protein Is Increased with Osmotic Shock-- Osmotic shock has been shown to cause insulin-resistance in 3T3-L1 adipocytes by inhibiting insulin activation of glucose transport, p70S6 kinase, glycogen synthesis, and lipogenesis (11). To further investigate the effects of osmotic shock on insulin action, 3T3-L1 adipocytes were treated for 30 min with either DMEM alone or DMEM containing 100 nM insulin, 600 mM sorbitol, or the combination of sorbitol and insulin. The cells were homogenized, fractionated by differential centrifugation, and then Western blot analyses were conducted on the various enriched subcellular compartments using a phosphotyrosine antibody (Fig. 1). As reported previously (10), insulin but not sorbitol, stimulated the tyrosine autophosphorylation of the insulin receptor (95-kDa band) in the plasma membrane (PM) fraction. Interestingly, the combination of sorbitol and insulin actually increased the tyrosine phosphorylation of the insulin receptor 2-fold compared with cells treated with insulin alone. Western blots using an insulin receptor antibody showed that the amount of receptor in the PM was identical for all conditions suggesting that sorbitol enhanced ligand-induced tyrosine autophosphorylation (data not shown). Analysis of the cytosol indicated that sorbitol did not affect insulin-stimulated tyrosine phosphorylation of IRS-1 (165-kDa band). Sorbitol alone did induce the tyrosine phosphorylation of several cytosolic proteins in the 115-130 kDa and 50-70 kDa range as was described previously (10). The LDM fraction is enriched in endosomes, the Golgi apparatus, as well as insulin-responsive Glut 4-containing vesicles (15). In addition, tyrosine-phosphorylated IRS-1 has been shown to bind and activate PI 3-kinase in the LDM (16). Osmotic shock did not prevent tyrosine-phosphorylated IRS-1 from associating with the LDM (Fig. 1), nor did it affect IRS-1 from binding and activating PI 3-kinase (data not shown (11)). In addition, sorbitol, but not insulin, increased the tyrosine phosphorylation of at least one protein in the 115-120-kDa protein range. The most dramatic effect, however, was the appearance of a 68-kDa protein that was tyrosine-phosphorylated in response to insulin alone, but not sorbitol, and whose phosphorylation was increased 6-10-fold when cells were treated with both insulin and sorbitol. Closer examination of the blot revealed that two additional proteins (55 and 75 kDa) had greater tyrosine phosphorylation content when cells were treated with both insulin and sorbitol compared with insulin alone, although the increases were small relative to that of pp68. Because the enhancement of pp68 phosphorylation by sorbitol was apparent from phosphotyrosine blots of whole cell lysates (data not shown), insulin must stimulate the phosphorylation of this protein rather than simply altering the subcellular localization of a sorbitol-induced tyrosine-phosphorylated 68-kDa protein from the cytosol to the LDM. The high density microsomes are enriched in endoplasmic reticulum but are also contaminated with organelles in the PM and LDM fractions (14, 15). The appearance of low levels of both tyrosine-phosphorylated insulin receptor and pp68 in this fraction (Fig. 1) is consistent with the cross-contamination. The mitochondrial/nuclear fraction contained few tyrosine-phosphorylated proteins (data not shown). Wortmannin had no significant effect on the tyrosine phosphorylation of any protein in any compartment with the exception that it reduced the sorbitol-induced phosphorylation of 115-120-kDa proteins in the cytosol and LDM.


View larger version (81K):
[in this window]
[in a new window]
 
Fig. 1.   Subcellular localization of insulin and osmotic shock-stimulated tyrosine-phosphorylated proteins in 3T3-L1 adipocytes. 3T3-L1 adipocytes were incubated for 15 min in the presence or absence of 100 nM wortmannin (W). Cells were then treated for 30 min with either DMEM alone (B) or DMEM supplemented with 100 nM insulin (I), 600 mM sorbitol (S), or the combination of sorbitol and insulin (S + I). Adipocytes were then washed three times with ice-cold phosphate-buffered saline, homogenized, and fractionated by differential centrifugation (see "Experimental Procedures"). PM, cytosol, high density microsomes (HDM), and LDM fractions were separated by SDS-polyacrylamide gel electrophoresis (50 µg of protein), immunoblotted, incubated with antiphosphotyrosine primary and 125I-labeled secondary antibodies, and then visualized by autoradiography.

Characterization of pp68 Phosphorylation-- Because pp68 was tyrosine-phosphorylated in response to insulin alone and its phosphorylation was dramatically elevated with osmotic shock and it was preferentially found in the LDM fraction, which also contains important insulin signaling molecules (17), we further characterized the phosphorylation of this protein. 100 nM insulin was added for varying periods of time to 3T3-L1 adipocytes that were first preincubated for 15 min with 600 mM sorbitol. Antiphosphotyrosine Western blots were then conducted on LDM isolated by subcellular fractionation. Fig. 2 shows that insulin-induced tyrosine phosphorylation of pp68 was rapid and complete after 1 min. Although this time frame is consistent with the insulin receptor phosphorylating p68 directly (18), we cannot rule out the possibility that insulin activates another tyrosine kinase, which, in turn, phosphorylates p68. Next we measured the insulin concentration dependence to determine whether the insulin response was because of the insulin receptor or the insulin-like growth factor-1 receptor (Fig. 2). Varying concentrations of insulin were added for 5 min to cells that were first pretreated for 15 min with 600 mM sorbitol. Tyrosine phosphorylation of pp68 was apparent with 5 nM insulin and saturated between 50 and 100 nM insulin suggesting that the insulin and not the insulin-like growth factor-1 receptor was responsible for stimulating the tyrosine phosphorylation (19).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 2.   The time course and concentration curve of insulin-stimulated tyrosine phosphorylation of pp68. 3T3-L1 adipocytes were preincubated for 15 min with 600 mM sorbitol in both experiments. 100 nM insulin was added for varying periods of time to measure the rate of insulin-stimulated pp68 phosphorylation. Different concentrations of insulin were added for 5 min in determining the hormone concentration dependence. After treatment, phosphotyrosine Western blot analyses were conducted on the LDM fraction prepared by differential centrifugation (see "Experimental Procedures"). Autoradiograms were quantitated by phosphoimaging. Quantitative data represent the mean ± S.E. of three independent experiments.

The effect of sorbitol on pp68 tyrosine phosphorylation was completely reversible (Fig. 3). Adipocytes were incubated in 600 mM sorbitol for 15 min followed by the addition of 100 nM insulin for 5 min. Cells were then washed and incubated for varying periods of time with DMEM containing insulin in the absence of sorbitol. The amount of tyrosine-phosphorylated pp68 in the LDM was quantitated from phosphotyrosine Western blots. The sorbitol induction of pp68 tyrosine phosphorylation was reversible and complete by 2.5 min after sorbitol removal. Maintaining insulin throughout the washout did not prevent the reversal.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   The effect of osmotic shock on insulin-stimulated pp68 tyrosine phosphorylation was rapidly reversible. 100 nM insulin was added for 5 min to adipocytes that were pretreated with 600 mM sorbitol for 15 min. Cells were then washed and incubated for varying periods of time in medium containing 100 nM insulin in the absence or presence of sorbitol. The amount of tyrosine-phosphorylated pp68 in the isolated LDM was quantitated from phosphotyrosine Western blots. Because the quantity of pp68 may vary with time without the removal of sorbitol (see Fig. 2), the amount of pp68 that remained after the sorbitol washout was normalized to the amount of pp68 that remained for the same period of time in the presence of sorbitol. Each data point represents the mean ± S.E. of three independent experiments.

pp68 Is a Peripheral Protein That Associates with the Triton X-100 Insoluble Fraction of the LDM-- Tyrosine-phosphorylated IRS-1 can be released from the LDM with high salt but not with Triton X-100 (17). Because of this observation in conjunction with the identification of filamentous actin in the IRS-1-containing LDM fraction, it was proposed that phosphorylated IRS-1 may be associated with the actin cytoskeleton (17). To determine the extraction properties of pp68, LDM prepared from sorbitol- and insulin-treated adipocytes was incubated with either 600 mM NaCl or 1% Triton X-100 for 30 min. The soluble and insoluble fractions were isolated after centrifugation for 1 h at 200,000 × g. Phosphotyrosine blots on the different fractions revealed that similarly to tyrosine-phosphorylated IRS-1, pp68 can be extracted with high salt but not with nonionic detergent (Fig. 4A). Glut 4, on the other hand, was removed from the LDM with 1% Triton X-100 but not high salt. Treatment of sorbitol- and insulin-treated cells with either the actin-depolymerizing agents, cytochalasin D or latrunculin B, or with the tubulin depolymerizing agent, nocodazole, failed to affect the levels of tyrosine-phosphorylated pp68 associated with the LDM (Fig. 4B). Although these compounds did not affect pp68 phosphorylation, confocal microscopy revealed that they did dramatically alter filamentous structures (data not shown).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 4.   pp68 is a peripheral membrane protein that associates with the Triton X-100 insoluble fraction of the LDM. A, 50 µg of LDM, prepared from adipocytes that were treated with 600 mM sorbitol for 15 min and then stimulated with insulin for 5 min, were incubated in buffer containing 600 mM NaCl or 1% Triton X-100 for 30 min at 4 °C. Soluble (S) and insoluble (P) material were isolated after centrifugation for 1 h at 200,000 × g. The distribution of pp68 and Glut 4 in the various fractions were determined by Western blots using phosphotyrosine and Glut 4 antibodies, respectively. B, 3T3-L1 adipocytes were incubated in DMEM alone for 3 h (CONTROL) or treated with 2 or 10 µM cytochalasin D (CD) for 3 h, 2 µM latrunculinB (LB) for 3 h, 3.3 µM nocodazole (NOC) for 3 h, or 33 µM nocodozole for 1 h. 600 mM sorbitol was then added for 15 min followed by a 5-min stimulation with 100 nM insulin. Phosphotyrosine blots were carried out on LDM isolated from the various treated cells.

The p42/44 and the p38 MAP Kinase Pathways Are Not Involved in pp68 Phosphorylation-- Osmotic stress is known to activate the p38 MAP kinase (20) and SAPK/JNK (21) pathways, and insulin activates the p42/44 MAP kinases (22). To verify the effects of insulin and sorbitol on these pathways, Western blot analyses were carried out on whole cell lysates from 3T3-L1 adipocytes that were incubated for 30 min with DMEM alone or with DMEM containing insulin, sorbitol, or the combination of insulin and sorbitol using phospho-specific antibodies directed against the activated forms of p42/44 MAP kinase, p38 MAP kinase, or SAPK/JNK. Fig. 5A shows that p42/44 MAP kinases were activated by both insulin and sorbitol and that these effects were additive in cells incubated with both insulin and sorbitol for 30 min. Wortmannin inhibited insulin but not sorbitol-induced activation. Inhibition of insulin activation of p42/44 MAP kinase by wortmannin has been previously reported in both 3T3-L1 adipocytes (23) and in skeletal muscle (24). Sorbitol dramatically increased the phosphorylation of p38 MAP kinase and SAPK/JNK. In agreement with Chen et al., (10), we saw very little if any effect of insulin on modulating the phosphorylation of p38 MAP kinase. This observation is in contrast to another recent report using 3T3-L1 adipocytes (25). Wortmannin had no effect on the stress-induced phosphorylation of p38 or SAPK/JNK. To address whether the enhancement of insulin-induced tyrosine phosphorylation of pp68 by sorbitol was mediated through the activation of the p42/44 or the p38 MAP kinase pathways, we examined whether MAP kinase inhibitors could affect pp68 accumulation. Adipocytes were preincubated with either DMEM alone, the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD 98059 (100 µM for 1 h), or with the p38 MAP kinase inhibitor SB 203580 (20 µM for 30 min). The cells were then treated with 600 mM sorbitol for 15 min followed by the addition of 100 nM insulin for 5 min. The amount of pp68 in the LDM was visualized by phosphotyrosine Western blot analysis. Fig. 5B illustrates that these inhibitors had no effect on pp68 accumulation, even though they did specifically inhibit the activation of these pathways by Western blot analyses using phospho-specific antibodies (data not shown). Because we are unaware of a specific inhibitor of the SAPK/JNK pathway, we cannot address the importance of this pathway in enhancing the insulin-induced phosphorylation of pp68.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 5.   The p42/44 and the p38 MAP kinase pathways are not involved in the enhancement by osmotic shock on the insulin-stimulated tyrosine phosphorylation of pp68. A, 3T3-L1 adipocytes were incubated for 15 min in the presence or absence of 100 nM wortmannin (W). Cells were then treated for 30 min with either DMEM alone (B) or DMEM supplemented with 100 nM insulin (I), 600 mM sorbitol (S), or the combination of sorbitol and insulin (S + I). Western blot analyses were carried out on 50 µg of whole cell lysates using phospho-specific antibodies directed against p42/44 MAP kinase, p38 MAP kinase, or SAPK/JNK. B, adipocytes were incubated in DMEM alone (CONTROL), the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD 98059 (100 µM for 1 h), or the p38 MAP kinase inhibitor SB 203580 (20 µM for 30 min). 600 mM sorbitol was then added for 15 min followed by 100 nM insulin for 5 min. Phosphotyrosine blots were carried out on LDM isolated from the various treated cells.

The Elimination of Possible Candidate and Interacting Proteins-- There are several known 68-70-kDa proteins that are phosphorylated on tyrosine. By immunoprecipitating these proteins from LDM prepared from sorbitol- and insulin-treated adipocytes using commercially available antibodies followed by phosphotyrosine Western blot analyses on the precipitated proteins, we eliminated the possibility of pp68 being SHC, Src, Fyn, IRS-3, Syp, PTP1C, p62Dok, Paxillin, or Sam68 (Table I). Using this same procedure, we determined that pp68 does not interact with IRS-1, PI 3-kinase, Glut 4-containing vesicles, RasGap, Fak, Cbl, Grb2, Pyk2, Nck, Src, or Cas (Table I). In all cases we verified that the commercial antibody did in fact immunoprecipitate the appropriate protein (data not shown).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Candidate and interacting proteins eliminated by negative immunoprecipitation results
Candidate and possible interacting proteins were specifically immunoprecipitated overnight from 0.5 to 1.0 mg of Triton X-100 solubilized LDM. The immunoprecipitates were subjected to SDS-polyacrylamide gel electrophoresis and analyzed by Western blot using PY20 antiphosphotyrosine antibodies.

pp68 Is an RNA-binding Protein-- It has been reported that insulin induces the tyrosine phosphorylation of a 70-kDa protein in A14 fibroblasts (26) that were pretreated with the phosphotyrosine phosphatase inhibitor phenylarsine oxide (PAO). This protein is not Sam68 but it does bind poly(U)-Sepharose. To determine whether pp68 binds to RNA, LDM containing pp68 were treated with RNase A for 2 h on ice prior to centrifugation at 200,000 × g. The phosphotyrosine blot (Fig. 6A) revealed that RNase treatment released pp68 but not Glut 4 from the LDM. To further confirm that pp68 is an RNA-binding protein, we tested the ability of pp68 to bind either poly(A)-Sepharose 4B, poly(U)-agarose, or agarose alone. pp68 was first released from the LDM with 600 mM NaCl. After removing the insoluble material by centrifugation, the salt concentration was diluted to 150 mM NaCl. After incubating pp68 with the RNA resins for 2 h, the samples were centrifuged, the pellets washed four times, and phosphotyrosine Western blot analyses were then carried out on the bound material. Fig. 6B illustrates that the majority of the pp68 starting material bound to poly(A) and poly(U) resins but not to agarose alone. Although these results indicate that pp68 binds RNA, they do not address whether the binding is direct or through another protein(s). In addition to pp68, the tyrosine-phosphorylated proteins pp55 and pp75 that we observed in the LDM fraction of Fig. 1 also bound to RNA.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 6.   pp68 binds RNA. A, 75 µg of LDM, prepared from cells treated with 600 mM sorbitol for 15 min and then 100 nM insulin for 5 min, were incubated in the presence or absence of 0.4 mg/ml RNase A for 2 h on ice. Soluble (S) and insoluble (P) material were isolated after centrifugation for 1 h at 200,000 × g. The distribution of pp68 and Glut 4 in the various fractions was determined by Western blots using phosphotyrosine and Glut 4 antibodies, respectively. B, 75 µg of LDM, prepared from cells treated with 600 mM sorbitol for 15 min and then 100 nM insulin for 5 min, were incubated in 600 mM NaCl for 30 min. After removing the insoluble material by centrifugation at 200,000 × g for 1 h, the salt concentration was diluted to 150 mM NaCl. Samples were then incubated for 2 h at 4 °C with 50 µl of agarose, 50 µl of poly(A)-Sepharose 4B, or 50 µg of poly(U)-agarose. After washing the pellets four times, phosphotyrosine Western blot analyses were carried out on the bound material. The TOTAL was a sample that was treated with high salt, centrifuged, diluted, but not incubated with the resins.

To address whether pp68 might be the same 70-kDa protein reported in A14 fibroblasts (26), 3T3-L1 adipocytes were incubated with PAO for 15 min followed by the addition of insulin for 5 min. Phosphotyrosine blots showed that a protein of 68 kDa accumulated in cells treated with PAO and insulin (Fig. 7). In addition to pp68, LDM from both sorbitol- and PAO-treated adipocytes contained proteins of 55, 75, and 95 kDa that exhibited enhanced insulin-stimulated tyrosine phosphorylation. Because PAO is a potent phosphotyrosine phosphatase inhibitor and the same pattern of insulin-stimulated tyrosine-phosphorylated proteins accumulated with both PAO and sorbitol, this suggests that osmotic shock may inhibit a phosphotyrosine phosphatase that leads to an increase in the insulin-stimulated tyrosine phosphorylation of several LDM proteins, especially pp68. The 95-kDa tyrosine-phosphorylated protein is probably the beta -subunit of the insulin receptor. Because the identity of the 70-kDa protein in A14 cells has not been reported, we cannot prove that pp68 is the same protein even though it appears to accumulate in the presence of PAO and insulin. However, unlike pp70 from A14 fibroblasts, pp68 does not bind to RasGAP or Grb2 (Table I). To examine whether other types of cellular stress can modulate insulin-induced tyrosine phosphorylation of pp68, we determined what effect oxidative stress, heat shock, potassium depletion, and inhibition of the Na+/K+-ATPase had on the accumulation of pp68. 3T3-L1 adipocytes were treated with either H2O2 for 15 min, heated to 43 °C for 90 min, depleted of K+ for 90 min, or incubated with 1 mM ouabain for 1 h prior to the addition of insulin for 5 min. The amount of pp68 in the LDM fraction was then analyzed from phosphotyrosine Western blots. None of these other conditions affected the level of pp68 (data not shown).


View larger version (88K):
[in this window]
[in a new window]
 
Fig. 7.   LDM from phenylarsine oxide- and insulin-treated 3T3-L1 adipocytes contain a 68-kDa phosphotyrosine-containing protein. 3T3-L1 adipocytes were treated for 15 min with DMEM alone (CON) or DMEM containing 600 mM sorbitol (SORB) or 35 µM PAO. 100 nM insulin was added or not for an additional 5 min. Phosphotyrosine Western blots were carried out on LDM prepared by differential centrifugation (see "Experimental Procedures").


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Insulin mediates its biological effects by activating an intrinsic tyrosine kinase upon binding of the hormone to specific cell surface receptors (1). Tyrosine phosphorylation of cellular substrates such as the IRS proteins (2), Gab-1 (27), p62DOK (28), and SHC (3) creates docking sites for multiple downstream signaling molecules. In this study we identified a downstream molecule in the insulin-signaling pathway that resides in the Triton X-100 insoluble fraction of the LDM of 3T3-L1 adipocytes and binds to RNA. The LDM fraction is enriched in endosomes, Golgi, and insulin responsive Glut 4-containing vesicles (15). In addition to pp68, other insulin signaling molecules, such as IRS-1, PI 3-kinase, and SHC, have been localized to the nonionic detergent-resistant fraction of the LDM (17). Hill et al. (29) identified 12 insulin-stimulated phosphoproteins in the LDM of 3T3-L1 adipocytes by combining metabolic labeling, subcellular fractionation, and two-dimensional gel electrophoresis. The majority of these proteins are also present in the detergent insoluble fraction, including a protein with a molecular mass of 66 kDa. It was not reported, however, whether this protein is phosphorylated on tyrosine. Because pp68 did not associate with IRS-1, PI 3-kinase, or SHC, this suggests that pp68 resides in a different compartment in the LDM. Triton X-100 insolubility is a known characteristic of the actin cytoskeleton, and long filamentous structures that resemble cytoskeletal elements have been observed by electron microscopy in the detergent insoluble fraction of the LDM (17). However, the observation that treatment of 3T3-L1 adipocytes with actin or tubulin-depolymerizing agents failed to affect the accumulation of pp68 in the LDM (Fig. 4B) suggests that pp68 is not associated with the membrane skeleton.

pp68 is not the first reported RNA-binding protein that is phosphorylated on tyrosine. Sam68 is a 68-kDa RNA-binding protein that is a substrate of the SRC tyrosine kinase during mitosis (30, 31). Upon phosphorylation, this protein binds to several SH3 and SH2 domain-containing signaling molecules such as Grb2 (32), phospholipase Cgamma -1 (32), Nck (33), and Cbl (34). The RNA-binding activity is inhibited upon tyrosine phosphorylation (35). Sam68 and pp68 appear to be different proteins based upon the failure to immunoprecipitate pp68 with Sam68-specific antibodies and on the ability of tyrosine-phosphorylated pp68 to bind RNA. A second 68-kDa RNA-binding protein that can be phosphorylated on tyrosine is heterogeneous nuclear ribonucleoprotein K (36). This protein, which recruits a diverse group of molecules that includes RNA, DNA, Vav, transcription repressors, and inducible kinases, has been implicated in transcription, RNA processing, and translation (37). Treatment with H2O2/vanadate induces the tyrosine phosphorylation of K protein in both cell culture and in mouse liver (36). Tyrosine phosphorylation was shown to enhance subsequent serine phosphorylation by protein kinase C as well as increase the association of K protein with Lck and the proto-oncoprotein Vav. K protein binds preferentially to poly(C) but not to poly(U)-RNA. Tyrosine phosphorylation inhibits the protein-RNA interaction in a similar manner to Sam68. Based on the observations that tyrosine-phosphorylated pp68 bound efficiently to poly(U)-RNA (Fig. 6), that pp68 did not accumulate in adipocytes with H2O2 and insulin, and that PAO and insulin could stimulate pp68 (Fig. 7) but not K protein (26) tyrosine phosphorylation, pp68 is probably not heterogeneous nuclear ribonucleoprotein K.

Osmotic stress enhanced the insulin-stimulated tyrosine phosphorylation of pp68 10-fold (Fig. 1). Although hypertonic shock activated both the p42/44 and the p38 MAP kinase pathways (Fig. 5A), inhibitors of these pathways did not affect pp68 accumulation, suggesting that induction of these pathways is not responsible for the enhancement of insulin-stimulated tyrosine phosphorylation of pp68. Other types of cellular stress, such as oxidative stress, heat shock, depletion of potassium, and inhibition of the Na+/K+-ATPase did not modulate insulin-induced tyrosine phosphorylation of pp68. PAO is a known tyrosine phosphatase inhibitor. Inhibition of two phosphotyrosine phosphatases, HA1 and HA2, by PAO results in the insulin-stimulated tyrosine phosphorylation of a 15-kDa fatty acid-binding protein (38). In addition, PAO blocks insulin-induced RAS activation by inhibiting the phosphotyrosine phosphatase Syp (39). Because the same pattern of insulin-stimulated tyrosine phosphorylated proteins, including pp68, accumulated in the LDM with both PAO and sorbitol treatment (Fig. 7), this suggests that osmotic shock may inhibit a phosphotyrosine phosphatase that leads to an increase in pp68. This would explain the increase in ligand-induced tyrosine phosphorylation of the insulin receptor in the PM fraction even though the amount of receptor did not change with hypertonic shock. Furthermore, inhibition of a phosphatase could result in an increase in the number of phosphorylated proteins. For example, treatment of cells with the serine phosphatase inhibitor, calyculin A, was shown to increase the basal phosphorylation of both AKT (11) and p70S6 kinase (12). Therefore, the increase in tyrosine phosphorylation of several proteins in the 115-130 kDa and 50-70 kDa range observed when adipocytes were treated with sorbitol alone (Fig. 1 (10)) may be due at least in part to an inhibition of phosphotyrosine phosphatase(s) rather than a stimulation of phosphotyrosine kinase(s).

The identity of pp68 remains elusive. We have eliminated a number of known 65-70-kDa tyrosine-phosphorylated proteins (Table I) as being pp68. Recently, PAO and insulin were shown to induce the tyrosine phosphorylation of a 70-kDa protein in A14 fibroblasts that could bind poly(U)-RNA (26). This protein was neither Sam68 nor heterogeneous nuclear ribonucleoprotein K. Because the identity of this 70-kDa protein has not been reported, we cannot address whether pp68 and pp70 are the same protein. In contrast to pp70, pp68 in the LDM did not associate with RasGAP or Grb2. We cannot rule out, however, that pp68 that resides in another compartment like the cytosol binds these SH2 and SH3 domain-containing proteins. In fact, all of the experiments on pp70 were done using total cell lysates as opposed to a LDM fraction, and osmotic shock was never used. pp68 has been purified to homogeneity, and although our initial attempts were unsuccessful, we are currently in the process of purifying enough material to obtain sequence information. Based on the elimination of known proteins and on the time and insulin concentration dependences of phosphorylation, pp68 could be a novel substrate of the insulin receptor tyrosine kinase whose ability to bind RNA may dictate its physiological function.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants DK38495 and DK50332 and by the Diabetes Research and Training Center at the Washington University Medical School.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Cell Biology and Physiology, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-4160; Fax: 314-362-7463; E-mail: mike@cellbio.wustl.edu.

Published, JBC Papers in Press, April 11, 2000, DOI 10.1074/jbc.M001937200

    ABBREVIATIONS

The abbreviations used are: IRS-1, insulin receptor substrate-1; SH, Src homology; PI 3-kinase, phosphatidylinositol 3-kinase; LDM, low density microsomes; poly(A), polyadenylic acid; poly(U), polyuridylic acid; DMEM, Dulbecco's modified Eagle's medium; MAP, mitogen-activated protein; SAPK, stress-activated protein kinase; JNK, c-Jun NH2-terminal kinase; PM, plasma membrane; PAO, phenylarsine oxide.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Cheatham, B., and Kahn, C. R. (1995) Endocr. Rev. 16, 117-142
2. White, M. F. (1998) Mol. Cell. Biochem. 182, 3-11
3. Pelicci, G. L., Lanfrancone, L., Grignani, F., McGlade, J., Cauallo, F., Forni, G., Nicoletti, I., Pawson, T., and Pelicei, P. G. (1992) Cell 70, 93-104
4. Sun, X. J., Crimmins, D. L., Myers, M. G. J., Miralpeix, M., and White, M. F. (1993) Mol. Cell. Biol. 13, 7418-7428
5. Sun, X. J., Pons, S., Asano, T., Myers, M. G. F., Jr., Glasheen, E., and White, M. F. (1996) J. Biol. Chem. 271, 10583-10587
6. Pons, S., Asano, T., Glasheen, E., Miralpeix, M., Zhang, Y., Fisher, T. L., Myers, M. G. J., Sun, X. J., and White, M. (1995) Mol. Cell. Biol. 15, 4453-4465
7. Shephard, P. R., Withers, D. J., and Siddle, K. (1998) Biochem. J. 333, 471-490
8. Skolnik, E. Y., Lee, C. H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., Myers, M. J., Backer, J. M., Ulrich, A., White, M. F., and Schlessinger, J. (1993) EMBO J. 12, 1929-1936
9. Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B., and Schlessinger, J. (1993) Nature 363, 85-88
10. Chen, D., Elmendorf, J. S., Olson, A. L., Li, X., Earp, H. S., and Pessin, J. E. (1997) J. Biol. Chem. 272, 27401-27410
11. Chen, D., Fucini, R. V., Olson, A. L., Hemmings, B. A., and Pessin, J. E. (1999) Mol. Cell. Biol. 19, 4884-4694
12. Parrott, L. A., and Templeton, D. J. (1999) J. Biol. Chem. 274, 24731-24736
13. Tordjman, K. M., Leingang, K. A., James, D. E., and Mueckler, M. M. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7761-7765
14. Piper, R. C., Hess, L. J., and James, D. E. (1991) Am. J. Physiol. 260, C570-C580
15. Simpson, I. A., Yver, D. R., Hissin, P. J., Wardzala, L. J., Darnieli, E., Salans, L. B., and Cushman, S. W. (1983) Biochim. Biophys. Acta 763, 393-407
16. Kelly, K. L., and Ruderman, N. B. (1993) J. Biol. Chem. 268, 4391-4398
17. Clark, S. F., Martin, S., Carozzi, A. J., Hill, M. M., and James, D. E. (1998) J. Cell Biol. 140, 1211-1225
18. Madoff, D. H., Martensen, T. M., and Lane, M. D. (1988) Biochem. J. 252, 7-15
19. White, M. F., Maron, R., and Kahn, C. R. (1985) Nature 318, 183-186
20. Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J. (1994) Science 265, 808-811
21. Matsuda, S., Kawasak, H., Moriguchi, T., Gotoh, Y., and Nishida, E. (1995) J. Biol. Chem. 270, 12781-12786
22. Boulton, T. G., Nye, S. H., Robbins, D. J., IP, N. Y., Radziejewska, E., Morgenbesser, S. D., DePinho, R. A., Panayotatos, N., Cobb, M. H., and Yancopoulos, G. D. (1991) Cell 65, 663-675
23. Suga, J., Yoshimasa, Y., Yamada, K., Yamamoto, Y., Inoue, G., Okamoto, M., Hayashi, T., Shigemoto, M., Kosaki, A., Kuzuya, H., and Nakao, K. (1997) Diabetes 46, 735-741
24. Wojtaszewski, J. F. P., Lynge, J., Jakobsen, A. B., Goodyear, L. J., and Richter, E. A. (1999) Am. J. Physiol. 277, E724-E732
25. Sweeney, G., Somwar, R., Ramlal, T., Volchuk, A., Ueyama, A., and Klip, A. (1999) J. Biol. Chem. 274, 10071-10078
26. Medema, J. P., Pronk, G. J., de Vries-Smits, A. M. M., Clark, R., McCormick, F., and Bos, J. L. (1996) Cell Growth Differ. 7, 543-550
27. Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K., and Wong, A. J. (1996) Nature 379, 560-563
28. Yamanashi, Y., and Baltimore, D. (1997) Cell 88, 205-211
29. Hill, M. M., Clark, S. F., and James, D. E. (1997) Electrophoresis 18, 2629-2637
30. Taylor, S. J., and Shalloway, D. (1994) Nature 368, 867-871
31. Fumagalli, S., Totty, N., Hsuan, J. J., and Courtneidge, S. A. (1994) Nature 368, 871-874
32. Richard, S., Yu, D., Bloumer, K. J., Hausladen, D., Olszowy, M. W., Connelly, P. A., and Shaw, A. S. (1995) Mol. Cell. Biol. 15, 186-197
33. Lawe, D. C., Hahn, C., and Wong, A. J. (1997) Oncogene 14, 223-231
34. Fusaki, N., Iwamatsu, A., Iwahima, M., and Fujisawa, J. (1997) J. Biol. Chem 272, 6214-6219
35. Wang, L. L., Richard, S., and Shaw, A. S. (1995) J. Biol. Chem. 270, 2010-2013
36. Ostrowski, J., Schullery, D. S., Denisenko, O. N., Higaki, Y., Watts, J., Aebersold, R., Stempka, L., Gschwendt, M., and Bomsztyk, K. (2000) J. Biol. Chem. 275, 3619-3628
37. Bomsztyk, K., Van Seuningen, I., Suzuki, H., Denisenko, O., and Ostrowski, J. (1997) FEBS Lett. 403, 113-115
38. Liao, K., Hoffman, R. D., and Lane, M. D. (1991) J. Biol. Chem. 266, 6544-6553
39. Noguchi, T., Matozaki, T., Horita, K., Fujioka, Y., and Kasuga, M. (1994) Mol. Cell. Biol. 14, 6674-6682


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. Cho, S. M. Park, T. D. Kim, J. H. Kim, K.-T. Kim, and S. K. Jang
BiP Internal Ribosomal Entry Site Activity Is Controlled by Heat-Induced Interaction of NSAP1
Mol. Cell. Biol., January 1, 2007; 27(1): 368 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Bannai, K. Fukatsu, A. Mizutani, T. Natsume, S.-i. Iemura, T. Ikegami, T. Inoue, and K. Mikoshiba
An RNA-interacting Protein, SYNCRIP (Heterogeneous Nuclear Ribonuclear Protein Q1/NSAP1) Is a Component of mRNA Granule Transported with Inositol 1,4,5-Trisphosphate Receptor Type 1 mRNA in Neuronal Dendrites
J. Biol. Chem., December 17, 2004; 279(51): 53427 - 53434.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Pesesse, K. Choi, T. Zhang, and S. B. Shears
Signaling by Higher Inositol Polyphosphates: SYNTHESIS OF BISDIPHOSPHOINOSITOL TETRAKISPHOSPHATE ("InsP8") IS SELECTIVELY ACTIVATED BY HYPEROSMOTIC STRESS
J. Biol. Chem., October 15, 2004; 279(42): 43378 - 43381.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ibarrola, H. Molina, A. Iwahori, and A. Pandey
A Novel Proteomic Approach for Specific Identification of Tyrosine Kinase Substrates Using [13C]Tyrosine
J. Biol. Chem., April 16, 2004; 279(16): 15805 - 15813.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Hresko and M. Mueckler
Identification of pp68 as the Tyrosine-phosphorylated Form of SYNCRIP/NSAP1. A CYTOPLASMIC RNA-BINDING PROTEIN
J. Biol. Chem., July 5, 2002; 277(28): 25233 - 25238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Li, V. K. Randhawa, N. Patel, M. Hayashi, and A. Klip
Hyperosmolarity Reduces GLUT4 Endocytosis and Increases Its Exocytosis from a VAMP2-independent Pool in L6 Muscle Cells
J. Biol. Chem., June 15, 2001; 276(25): 22883 - 22891.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/24/18114    most recent
M001937200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hresko, R. C.
Right arrow Articles by Mueckler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hresko, R. C.
Right arrow Articles by Mueckler, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals